Aurobindo Pharma Limited

Aurobindo Pharma Limited engages in the research development manufacture and sale of active pharmaceutical ingredients generic pharmaceuticals and related services in India. The company primarily offers oral solids injectables and over-the-counter drugs as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular central nervous system gastroenterology anti-allergies anti-diabetics anti-retroviral antibiotics dermatology respiratory and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition the company develops and manufactures peptides as well as biocatalysts for use in the pharmaceutical and chemical industries. Further it is developing biosimilar inhalers transdermal patches vaccines topicals and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad India.